Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Meiosis regulator for oocyte development (MIOS) is a protein-coding gene, highly conserved, and a component of the GATOR2 complex, which is involved in the regulation of the mTORC1 pathway in response to amino acid availability[2][3]. It plays roles in cellular response to amino acid starvation, localization of protein complexes, and has a positive regulatory effect on TOR signaling. Although its name implies involvement in oocyte meiosis regulation, functional annotation in human and mouse points to broader roles in cell growth and metabolic regulation[1][2][3][4]. There are currently no approved drugs targeting MIOS, nor is MIOS established as a therapeutic target. Its molecular family is best described as a WD repeat-containing protein and a component of multiprotein regulatory complexes[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on meiosis regulator for oocyte development (MIOS).